Sign in

CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company

NextCure, Inc.

Sign in to watch
Ticker
NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475231247
Phone
240-399-4900
Business address
2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
Open-market buys, last 90 days
$77,590
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$77,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$78K 10% owner 2 filings
Date Insider Transaction Shares Price Value Owned after
2019-05-13 SHANNON TIMOTHY M Director Conversion +729,599 1,918,575
2019-05-13 SHANNON TIMOTHY M Director Conversion +285,867 2,204,442
2019-05-13 SHANNON TIMOTHY M Director Purchase +50,000 $15.00 $750K 2,254,442
2019-05-13 SHANNON TIMOTHY M Director Conversion · Series A-1 Preferred Stock −3,582,000 0
2019-05-13 SHANNON TIMOTHY M Director Conversion · Series A-2 Preferred Stock −5,970,000 0
2019-05-13 SHANNON TIMOTHY M Director Conversion · Series A-3 Preferred Stock −5,861,455 0
2019-05-13 SHANNON TIMOTHY M Director Conversion · Series B-1 Preferred Stock −2,296,605 0
2019-05-13 Khuong Chau Quang Director Conversion +445,866 445,866
2019-05-13 Khuong Chau Quang Director Conversion +743,110 1,188,976
2019-05-13 Khuong Chau Quang Director Conversion +729,599 1,918,575
2019-05-13 Khuong Chau Quang Director Conversion +442,438 2,361,013
2019-05-13 Khuong Chau Quang Director Purchase +350,000 $15.00 $5.3M 2,711,013
2019-05-13 Khuong Chau Quang Director Conversion · Series A-1 Preferred Stock −3,582,000 0
2019-05-13 Khuong Chau Quang Director Conversion · Series A-2 Preferred Stock −5,970,000 0
2019-05-13 Khuong Chau Quang Director Conversion · Series A-3 Preferred Stock −5,861,455 0
2019-05-13 Khuong Chau Quang Director Conversion · Series B-1 Preferred Stock −3,554,466 0
2019-05-13 Xu Stella Director Conversion +978,570 978,570
2019-05-13 Xu Stella Director Purchase +125,000 $15.00 $1.9M 1,103,570
2019-05-13 Xu Stella Director Conversion · Series B-2 Preferred Stock −7,861,636 0
2019-05-13 CANAAN X L.P. 10% owner Conversion +445,866 445,866

Page 9 of 10 · 197 trades